For the Inventor, By the Inventor

Enter assignee name

Dreieich, Germany

Biotest Pharma Gmbh

USPTO Granted Patents = 23

% Expired Patents = 4.3

CIPO Patents = 1

Forward Citations = 523

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Wolfgang Moller (11 out of 12 patents)

Wolfgang Stephan (10 out of 20 patents)

Herbert Dichtelmuller (7 out of 7 patents)

4. Norbert Kothe (7 out of 9 patents)

5. Dieter Rudnick (6 out of 14 patents)

6. Michael Kloft (5 out of 5 patents)

7. Detlef Piechaczek (5 out of 5 patents)

8. Hans Schleussner (3 out of 8 patents)

9. Michael Kraus (3 out of 3 patents)

10. Bertram Eichentopf (3 out of 4 patents)

11. Ronald Kotitschke (2 out of 9 patents)

12. Ulf Bethke (2 out of 2 patents)

13. Detlef Rohm (2 out of 2 patents)

14. Henry Hies (2 out of 2 patents)

15. Roland Beliard (1 out of 14 patents)

23 patents: Sort by Forward Citations

1. 7041798 - Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use (2006-05-09),

2. 5851524 - Human monoclonal anti-rhesus (D) antibodies and cell lines producing same (1998-12-22),

3. 5710132 - Use of bovine colostral milk as a preparation for the protection of the (1998-01-20),

4. 5643759 - Method for preparing bispecific monoclonal antibodies (1997-07-01),

5. 5576040 - Process for the sterile filtration of milk (1996-11-19),

6. 5410025 - Unmodified intravenously administered immunoglobulin preparations (1995-04-25),

7. 5190752 - Intravenously administerable polyclonal immunoglobulin preparation (1993-03-02),

8. 5164487 - Manufacturing intravenous tolerable immunoglobulin-G preparation (1992-11-17),

9. 5147548 - Colostrum filtered sterile (1992-09-15),

10. 5143838 - Method of producing thrombin from factor II using calcium ions for the (1992-09-01),

11. 5099003 - Method of preparing a sterile plasma-protein solution containing (1992-03-24),

12. 5075425 - Process for the preparation of a pharmaceutical which contains IgG, IgA (1991-12-24),

13. 5071961 - Method of enrichment of coagulation factors II, VII, IX and X (1991-12-10),

14. 5061789 - Method of isolating blood-clotting factor IX (1991-10-29),

15. 5041537 - Method of preparing a high-purity, virus safe, biologically active (1991-08-20),

Company Overview

Biotest Pharma GmbH, headquartered in Dreieich, Germany, specializes in the development and production of biopharmaceutical products, particularly in the fields of immunology and hematology. The company focuses on therapies derived from human blood plasma, aiming to address critical medical needs. With a commitment to innovation, Biotest engages in extensive research to enhance treatment options for patients with complex health conditions, contributing to advancements in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

23 Patents

#3 in Dreieich

#1,979 in Germany

#27,649 in the World

Dreieich, Germany

Biotest Pharma Gmbh

Forward Citations = 523

28 inventors:

Wolfgang Moller (11 out of 12 patents)

Wolfgang Stephan (10 out of 20 patents)

Herbert Dichtelmuller (7 out of 7 patents)

4. Norbert Kothe (7 out of 9 patents)

5. Dieter Rudnick (6 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biotest Pharma Gmbh. Retrieved from https://idiyas.com/company/biotest-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…